Publications in collaboration with researchers from Hospital Universitario La Fe (10)

2023

  1. Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning

    Thrombosis Research, Vol. 228, pp. 181-188

2021

  1. Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

    Annals of Hematology, Vol. 100, Núm. 4, pp. 1023-1029

2020

  1. High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

    European Journal of Cancer, Vol. 141, pp. 193-198

2019

  1. Management and supportive treatment of frail patients with metastatic pancreatic cancer

    Journal of Geriatric Oncology, Vol. 10, Núm. 3, pp. 398-404

2018

  1. Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer

    European Respiratory Journal

2017

  1. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

    Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681

2016

  1. Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

    British Journal of Cancer, Vol. 115, Núm. 7, pp. 789-796

2015

  1. Erratum: Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study [Support Care Cancer, DOI 10.1007/s00520-015-2809-3]

    Supportive Care in Cancer

  2. Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study

    Supportive Care in Cancer, Vol. 23, Núm. 9, pp. 2833-2840

2007

  1. Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease

    Haematologica, Vol. 92, Núm. 11, pp. 1489-1494